AB022. Biosynthetic implants for corneal regeneration in patients at high risk of rejecting donor transplantation
Annals of Eye Science(2019)
Abstract
Background: Patients with inflammation or severe corneal pathology are often at high risk of rejecting the human donor corneas that they receive during transplantation. Our goal was to determine whether cell-free implants incorporating phosphorylcholine-based polymer, 2-methacryloyloxyethyl phosphorylcholine (MPC), which has inflammation suppressing properties, can support repair and regeneration of ulcerated, high-risk corneas.
MoreTranslated text
Key words
corneal regeneration,biosynthetic implants,donor transplantation
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined